Search - tctmd.com

Displaying 401 - 420 of 1041

Sort: Relevancy | Date

A secondary analysis from ASPREE sets up two large RCTs testing statins in an elderly primary-prevention population.

News Daily News

Statins Cut CV Risk but Don’t Boost Disability-Free Survival in Healthy Elderly

Michael O'Riordan

July 06, 2020

News Daily News

Most Stable Angina Patients Not Taking First-line Meds

Shelley Wood

June 18, 2020

News Daily News

Sodium Fluoride PET Bests CT for Predicting MI in CAD Patients

Yael L. Maxwell

June 15, 2020

News Daily News

COVID-19 Upset: Researchers Retract Lancet, NEJM Papers on Hydroxychloroquine, ACEi/ARBs

Michael O'Riordan

June 04, 2020

News Daily News

Carotid Endarterectomy Little Help in Asymptomatic Patients: VA Study

Todd Neale

June 04, 2020

News Daily News

Swedish Data ‘Corroborate’ FFR’s Survival Benefit Seen in RCTs

Caitlin E. Cox

June 03, 2020

News Features

Hydroxychloroquine: No Help, Clear Harm in COVID-19 RCT and Cohort Studies

Shelley Wood

May 20, 2020

News Daily News

Coronary Calcium-Guided Statin Strategy Cost-effective in African-Americans

Michael O'Riordan

May 15, 2020

News Daily News

FOURIER Surveys Reassure About Cognitive Safety of Evolocumab

Todd Neale

May 06, 2020

News Daily News

COVID-19, ACE Inhibitors, and ARBs: Multiple Studies Show No Increased Risk

Michael O'Riordan

May 05, 2020

News Daily News

How COVID-19 Promotes Thrombosis, Posing Problems for Drug-Drug Interactions

Michael O'Riordan

April 22, 2020

News

As COVID-19 Spreads, US Cath Labs Ponder Fibrinolytics for STEMI

Michael O'Riordan

April 17, 2020

News Features

‘Salvage What We Can’: Cardiology Clinical Trials in Turmoil Amid COVID-19

Michael O'Riordan

April 07, 2020

News Conference News ACC 2020

Alirocumab Successfully Reduces LDL Cholesterol in Homozygous FH: ODYSSEY HoFH

Yael L. Maxwell

April 06, 2020

News Conference News ACC 2020

Icosapent Ethyl’s CV Benefit Closely Tied to Serum EPA Levels: REDUCE-IT

Todd Neale

April 02, 2020

News Conference News ACC 2020

Pooled Inclisiran Data: Safe LDL-Lowering, Plus Hints of Fewer CVD Events

Michael O'Riordan

April 02, 2020

Hope for these hard-to-treat patients: more than half saw ≥ 50% decrease at 24 weeks, regardless of LDL receptor function.

News Conference News ACC 2020

Evinacumab Cuts LDL Cholesterol in Homozygous FH

Yael L. Maxwell

April 01, 2020

News Conference News ACC 2020

Colchicine Cost-effective in Canada, and Even in the US: COLCOT

Caitlin E. Cox

March 28, 2020

News Daily News

Inclisiran Data in NEJM Prompt Talk of What Comes Next

Caitlin E. Cox

March 24, 2020

News Daily News

New Review Tracks ‘Evolving’ CV Impact of COVID-19 on Patients, Hospitals

Michael O'Riordan

March 20, 2020

Advertisement

Statins Cut CV Risk but Don’t Boost Disability-Free Survival in Healthy Elderly

Most Stable Angina Patients Not Taking First-line Meds

Sodium Fluoride PET Bests CT for Predicting MI in CAD Patients

COVID-19 Upset: Researchers Retract Lancet, NEJM Papers on Hydroxychloroquine, ACEi/ARBs

Carotid Endarterectomy Little Help in Asymptomatic Patients: VA Study

Swedish Data ‘Corroborate’ FFR’s Survival Benefit Seen in RCTs

Hydroxychloroquine: No Help, Clear Harm in COVID-19 RCT and Cohort Studies

Coronary Calcium-Guided Statin Strategy Cost-effective in African-Americans

FOURIER Surveys Reassure About Cognitive Safety of Evolocumab

COVID-19, ACE Inhibitors, and ARBs: Multiple Studies Show No Increased Risk

How COVID-19 Promotes Thrombosis, Posing Problems for Drug-Drug Interactions

As COVID-19 Spreads, US Cath Labs Ponder Fibrinolytics for STEMI

‘Salvage What We Can’: Cardiology Clinical Trials in Turmoil Amid COVID-19

Alirocumab Successfully Reduces LDL Cholesterol in Homozygous FH: ODYSSEY HoFH

Icosapent Ethyl’s CV Benefit Closely Tied to Serum EPA Levels: REDUCE-IT

Pooled Inclisiran Data: Safe LDL-Lowering, Plus Hints of Fewer CVD Events

Evinacumab Cuts LDL Cholesterol in Homozygous FH

Colchicine Cost-effective in Canada, and Even in the US: COLCOT

Inclisiran Data in NEJM Prompt Talk of What Comes Next

New Review Tracks ‘Evolving’ CV Impact of COVID-19 on Patients, Hospitals

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content